Navigation Links
Children's HIV Drugs May Cause High Cholesterol
Date:8/5/2011

FRIDAY, Aug. 5 (HealthDay News) -- Children with HIV who receive antiretroviral treatments have persistently high cholesterol and other blood fat (lipid) levels, and would benefit from guidelines aimed at reducing their long-term heart risks, researchers say.

The findings are published in JAIDS: Journal of Acquired Immune Deficiency Syndromes.

"Formal guidelines are the first crucial step in minimizing cardiovascular disease complications and maximizing quality of life in this vulnerable population," the authors of an editorial said in a journal news release. The most effective strategy probably consists of a "lipid-friendly" drug regimen -- meaning medications that don't affect blood fats -- along with lifestyle changes, such as diet and exercise, they said.

The editorial accompanies two studies in the Aug. 15 issue that examined blood fats in children treated for HIV.

In one study, led by Denise L. Jacobson of Harvard School of Public Health, the researchers followed 240 HIV-infected children with high cholesterol for two years. During this time, the children had persistently high lipid levels. Cholesterol levels dropped to normal in only about one-third of the children.

Cholesterol levels were more likely to decline when changes were made to their antiretroviral treatment, the researchers found. In most cases, medication changes were related to the HIV, not lipid levels. Only 15 of the children were given drugs specifically to manage their cholesterol.

In a separate study, researchers at the Imperial College School of Medicine, London, compared the effect of different HIV drugs on 449 HIV-infected children's lipid levels. They found all of the drugs caused a surge in cholesterol. The class of HIV drugs known as protease inhibitors, in particular, triggered the biggest increase.

Within five years, 10 percent of children developed low-density lipoprotein ("bad") cholesterol levels above the 95th percentile. But based on those numbers, only three patients needed to take cholesterol medication.

Because HIV-infected children are likely to live well into adulthood, the researchers said treatment strategies need to be developed that will protect them against heart disease later in life.

"Clinical trials are required to develop and test intervention strategies to protect against cardiovascular disease in children born with HIV, growing into adult life," Dr. Margaret P. Rhoads of Imperial College and co-authors wrote in the news release.

More information

The U.S. Centers for Disease Control and Prevention provides statistics on HIV/AIDS among children.

-- Mary Elizabeth Dallas

SOURCE: JAIDS: Journal of Acquired Immune Deficiency Syndromes, news release, Aug. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
2. Parents Want Electronic Access to Their Childrens Docs: Survey
3. Cholesterol-lowering drugs may help prevent recurrent strokes in younger people
4. Are Newer MS Drugs Worth Their High Price Tag?
5. Cancer drugs may help treatment of schizophrenia
6. New mouse model for testing cancer drugs
7. Drugs Can Bring HIV-Infected Africans Normal Life Spans
8. UNC receives NIH grant to develop and test new drugs to block HIV infection
9. Drugs May Prevent HIV Spread Among Heterosexuals
10. Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid
11. The metabolic effects of antipsychotic drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Children's HIV Drugs May Cause High Cholesterol
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology: